Tomorrow prestentation's question: Soon allowed to PR something about the Nantcell plan? They renewed agreement at 10/03/18, and CytRx payd $4 M to help trials. I'm afraid SK'll 'present' the foggy possibilty with some BP in LADR trials. Hope dies last ...! GLTY & all CYTR SHs
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.